KX-826 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Payward’s Bitnomial acquisition shows Kraken is building infrastructure, not just buying growth

Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal

Badger Meter (BMI) adds UK sewer monitoring platform UDlive in $100m expansion move

Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?

Kintor Pharmaceutical completes patient enrollment in phase 2 clinical trial of KX-826 in acne vulgaris

Read More

Pharma Industry News

Kintor Pharmaceutical completes patient enrollment in KX-826 phase 2 trial

Kintor Pharmaceutical said that it has wrapped up patient enrollment for the phase 2 clinical trial of KX-826…

byPallavi Madhiraju

October 16, 2022

web analytics